Quote | SAB Biotherapeutics Inc. (NASDAQ:SABS)
Last: | $4.09 |
---|---|
Change Percent: | 0.0% |
Open: | $4.01 |
Close: | $4.09 |
High: | $4.2 |
Low: | $3.91 |
Volume: | 12,185 |
Last Trade Date Time: | 05/13/2024 03:00:00 am |
News | SAB Biotherapeutics Inc. (NASDAQ:SABS)
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progres...
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIg...
Message Board Posts | SAB Biotherapeutics Inc. (NASDAQ:SABS)
Subject | By | Source | When |
---|---|---|---|
$SABS bears are running | XenaLives | investorshub | 05/14/2023 11:30:21 PM |
$SABS should we be shorting? | crudeoil24 | investorshub | 05/13/2023 2:03:54 AM |
Price gaining | XenaLives | investorshub | 05/11/2023 12:26:26 AM |
The gaining | XenaLives | investorshub | 05/09/2023 12:34:18 PM |
$SABS The now | XenaLives | investorshub | 05/06/2023 2:17:08 PM |
News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Inc. Company Name:
SABS Stock Symbol:
NASDAQ Market:
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS) (the "Company" or "SAB"), a clinical-stage biopharmaceutical company w...
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progres...
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIg...